Biora Therapeutics, Inc.
BIORDelisted Jun 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001580063
Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.
Holders of 5% or more of BIOR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biora Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Athyrium Opportunities III Co-Invest 1 LP | 13D/A | 49.90%3.42M shares | – | Mar 26, 20251 filing | Mar 26, 2025 | SEC |
| Context Capital Management, LLC | 13G | 9.90%2.99M shares | New | Mar 20, 20241 filing | Mar 20, 2024 | SEC |
| Davidson Kempner Capital Management LP | 13G/A | 9.90%906.2K shares | – | Aug 4, 20251 filing | Aug 4, 2025 | SEC |
| Taggett Margaret Ellen | 13G | 6.60%297.0K shares | New | Aug 4, 20251 filing | Aug 4, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Biora Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 4, 20254:15 PM ET | Davidson Kempner Capital Management LPand 3 others | 13G/A | 9.90%906.2K shares | – | Jun 30, 2025 | SEC |
| Aug 4, 20258:00 AM ET | Taggett Margaret Ellen | 13G | 6.60%297.0K shares | New | Apr 7, 2025 | SEC |
| Jul 10, 20259:51 AM ET | Context Capital Management, LLCand 4 others | 13G/A | 0.50%22.0K shares | –Below 5% | Jun 30, 2025 | SEC |
| Mar 26, 20259:30 PM ET | Athyrium Opportunities III Co-Invest 1 LPand 8 others | 13D/A | 49.90%3.42M shares | – | Mar 24, 2025 | SEC |
| Mar 20, 20246:29 PM ET | Context Capital Management, LLCand 4 others | 13G | 9.90%2.99M shares | New | Mar 12, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Biora Therapeutics, Inc. shares.
No Form 144 notices for Biora Therapeutics, Inc. are on file.